The Canada-based units of Boehringer Ingelheim and IBM will work together to employ blockchain recordkeeping technology in clinical trials, in what they say will be a first in the country.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,